江西师范大学学报(自然科学版)
江西師範大學學報(自然科學版)
강서사범대학학보(자연과학판)
JOURNAL OF JIANGXI NORMAL UNIVERSITY(NATURAL SCIENCES EDITION)
2014年
6期
635-638
,共4页
张义军%刘义稳%李德江
張義軍%劉義穩%李德江
장의군%류의은%리덕강
TG101348%合成%工艺研究
TG101348%閤成%工藝研究
TG101348%합성%공예연구
TG101348%synthesis%technical study
研究了骨髓增殖性肿瘤治疗药物TG101348的合成工艺.将2,4-二羟基-5-甲基嘧啶与三氯氧磷、氨水发生氯化、取代反应生成2-氯-4-氨基-5-甲基嘧啶(Ⅲ),而后Ⅲ与N-叔丁基-3-溴苯磺酰胺(Ⅰ)发生Buchwald偶联反应得到3-[(2-氯-5-甲基-4-嘧啶基)胺基]-N-(叔丁基)苯磺酰胺(Ⅳ),Ⅳ再与CH3 OH-HCl反应得到3-[(2-氯-5-甲基-4-嘧啶基)胺基]-N-(叔丁基)苯磺酰胺盐酸盐(Ⅴ),最后Ⅴ与1-(4-氨基苯氧乙基)吡咯烷(Ⅵ)发生亲核取代反应得到TG101348,HPLC测得TG101348的纯度为99.7%.
研究瞭骨髓增殖性腫瘤治療藥物TG101348的閤成工藝.將2,4-二羥基-5-甲基嘧啶與三氯氧燐、氨水髮生氯化、取代反應生成2-氯-4-氨基-5-甲基嘧啶(Ⅲ),而後Ⅲ與N-叔丁基-3-溴苯磺酰胺(Ⅰ)髮生Buchwald偶聯反應得到3-[(2-氯-5-甲基-4-嘧啶基)胺基]-N-(叔丁基)苯磺酰胺(Ⅳ),Ⅳ再與CH3 OH-HCl反應得到3-[(2-氯-5-甲基-4-嘧啶基)胺基]-N-(叔丁基)苯磺酰胺鹽痠鹽(Ⅴ),最後Ⅴ與1-(4-氨基苯氧乙基)吡咯烷(Ⅵ)髮生親覈取代反應得到TG101348,HPLC測得TG101348的純度為99.7%.
연구료골수증식성종류치료약물TG101348적합성공예.장2,4-이간기-5-갑기밀정여삼록양린、안수발생록화、취대반응생성2-록-4-안기-5-갑기밀정(Ⅲ),이후Ⅲ여N-숙정기-3-추분광선알(Ⅰ)발생Buchwald우련반응득도3-[(2-록-5-갑기-4-밀정기)알기]-N-(숙정기)분광선알(Ⅳ),Ⅳ재여CH3 OH-HCl반응득도3-[(2-록-5-갑기-4-밀정기)알기]-N-(숙정기)분광선알염산염(Ⅴ),최후Ⅴ여1-(4-안기분양을기)필각완(Ⅵ)발생친핵취대반응득도TG101348,HPLC측득TG101348적순도위99.7%.
The synthetic technique of TG101348 for treating bone marrow hyperplastic tumor was studied. 2-chloro-4-amino-5-methyl-pyrimidine(Ⅲ)was prepared by chlorination and substitution reaction of 2 ,4-dihydroxy-5-meth-ylpyrimidinnel,phosphorus oxychloride and ammonium hydroxide.Ⅲreacted with 3-bromo-N-t-butyl benzenesulfon-ic amide(Ⅰ) to give 3-[( 2-chloro-5-methyl-4-pyrimidinyl ) amino ]-N-t-butyl benzenesulfonic amide(Ⅳ) by Buchwald coupling reaction.Ⅳ reacted with CH3 OH-HCl to afford 3-[(2-chloro-5-methyl-4-pyrimidinyl)amino]-N-tert-butyl benzenesuiphon amide hydrochloride(Ⅴ). TG101348 was synthesized by nucleophilic substitution re-action of the intermediate Ⅴ and Ⅵ. HPLC purity is 99 . 7%.